Is psyllium husk safe during pregnancy?

Nobody has measured it well enough to say. The one randomized trial of psyllium itself in pregnancy, in first-time mothers aged 20 to 30 in Iran, reported less constipation, hemorrhoids and anal fissure than placebo (p below 0.001), and its abstract gives no sample size, no dose and no side effects. A Cochrane review of every constipation treatment tested in pregnancy found 4 trials, with data from 180 women, and concluded the evidence was too limited to judge the safety of any of them.

Unsettled. Psyllium is widely used in pregnancy. In a Danish cohort of 225 pregnant women, 15 of them (6.7%) were taking psyllium husk fiber for constipation. No study we found followed women like these to count birth defects, preterm births or birth weight. So the absence of reported harm here is an absence of measurement, and it should not be read as reassurance.

What the trials found

The one psyllium trial

The trial ran at an obstetric clinic of Shiraz University of Medical Sciences. Women took psyllium powder twice a day from the start of the third trimester, or a placebo, under double-blind conditions. The abstract reports fewer cases of constipation, hemorrhoids and fissure in the psyllium group and stops there. It is not indexed in PubMed, and we could not get the full text. A letter in the same journal, written by a reader of the full text, put constipation at 18% on placebo against 5% on psyllium, and the same full text gives hemorrhoids in only 1% on placebo, a figure that looks implausibly low. A second letter pointed out that the trial used no standard definitions of its outcomes and reported no data on women who dropped out. Nobody in this trial assessed safety for the baby.

Fiber supplements in general

The Cochrane review found one trial of a fiber supplement in 40 pregnant women with constipation. Stools rose by 2.24 a week compared with no treatment (95% CI 0.96 to 3.52), on moderate-quality evidence. The fiber in that trial was not psyllium. The same review found one trial of 140 women comparing stimulant laxatives with bulk-forming ones, the family psyllium belongs to. Stimulant laxatives relieved constipation more often (RR 1.59, 95% CI 1.21 to 2.09) and also caused more abdominal discomfort (RR 2.33, 95% CI 1.15 to 4.73). That review did not publish the underlying counts for these ratios in the passage we have, so we cannot give them per 100 women.

Longer use, in trials of other soluble fibers

In a randomized trial of 376 women at high risk of metabolic syndrome, a daily soluble fiber supplement taken from weeks 11 to 13 until delivery lowered the need for constipation medicine. The authors wrote that their study verified the safety of long-term soluble fiber in pregnancy. Their abstract does not name the fiber and gives no count of side effects. A 2022 meta-analysis of 8 randomized trials of added fiber in women with gestational diabetes found lower blood glucose two hours after meals, a standardized difference of 0.69 (95% CI 0.51 to 0.88). The fiber types varied and psyllium was not analyzed on its own. Both studies point the same direction and neither is a test of psyllium.

Who should be careful

The safety question in pregnancy is open because the data are thin. The Cochrane review found no usable data on dehydration, electrolyte problems, acute allergic reactions or asthma for any constipation treatment in pregnancy. That is the honest limit of this page.

The known risks of psyllium apply to pregnant women as much as to anyone. Psyllium swells as it absorbs water. US rules require every psyllium product to warn that taken without enough fluid it can swell and block the throat or esophagus and cause choking, and to tell people to drink at least 8 ounces of liquid with each dose. Granules swallowed dry or sprinkled on food have been off the US list of ingredients recognized as safe and effective since March 2007, because the data were inadequate. Powders stirred into a full glass of liquid are a different form and are not on that list. A man of 26 on an extreme slimming diet developed a bowel blockage after eating psyllium foods, and his doctors warn that psyllium taken without enough fluid can block the gut. That is a single case.

Side effects in the constipation trials outside pregnancy were minor. In one small trial, 2 people on psyllium (18%) had abdominal pain against none on control. Allergy is possible. A nurse whose only earlier contact with psyllium was handing out psyllium laxatives had anaphylaxis the first time she ate a psyllium cereal. That is one case. The authors of the Danish cohort flag delayed absorption of other drugs as the concern with psyllium in pregnancy. Their table was cut off in our copy, so we cannot say which drugs they meant.

Not for everyone. If you are pregnant and want to use psyllium, take it as a powder stirred into a full glass of liquid, never as dry granules. If nausea or vomiting stops you drinking enough, or you take other medicines at fixed times, check the timing with your midwife or doctor.

What expert bodies say

We found no statement from an expert body on psyllium in pregnancy specifically that we could quote. The UK NICE guidance on constipation in pregnancy was blocked to us outside the UK. The US rules above are about the product form and the fluid it needs, and they do not mention pregnancy. The Cochrane review is the closest thing to an expert verdict on safety, and its verdict is that there is not enough evidence to judge.

How we searched

What would change this answer

• Results from NCT06867861, a registered trial of psyllium at 16 g a day in women with gestational diabetes, recruiting with 110 women planned and no results posted.
• Any study that follows women who took psyllium in pregnancy and counts birth defects, preterm births and birth weight. We found none.
• A properly reported trial of psyllium for constipation in pregnancy, with its size, dose and side effects published. The one we have cannot carry the weight of a safety answer.

More on psyllium itself: psyllium husk.

Sources

1. ev-psypr-01 · Randomized controlled trial(s) · randomized double-blind placebo-controlled trial · n = —
   Treatment group received psyllium powder twice daily while control group received placebo. ... Comparison between three outcome variables (hemorrhoid, fissure and constipation) revealed significant difference in group A and group B in compare with group B, p < 0.001).
   
   Who: primigravid women aged 20 to 30 at the onset of the third trimester, obstetric clinic of Shiraz University of Medical Sciences
   Effect: constipation, hemorrhoids and fissure lower with psyllium than placebo, p < 0.001; event counts, dose and adverse events not given in the abstract
   Certainty: The only RCT of psyllium specifically in pregnancy; not in PubMed, full text unavailable. Letter by Indrasena 2013 (DOI 10.17795/acr-14299) from the full text: constipation 18% on placebo vs 5% on psyllium, hemorrhoids only 1% on placebo (implausibly low). Letter by Sepehrimanesh 2016: no standard outcome definitions, ITT, or dropout data. Fetal safety was not assessed.
   Iranian Journal of Colorectal Research (Annals of Colorectal Research), 2013, 1: The Effect of Oral Psyllium Herbal Laxative Powder in Prevention of Hemorrhoids and Anal Fissure during Pregnancy, a Randomized Double Blind Clinical Trial · checked 2026-10-07 · we read the abstract
2. ev-psypr-02 · Meta-analysis or systematic review · Cochrane systematic review of randomized and quasi-randomized trials · n = 40
   Pregnant women who received fibre supplementation had significantly higher frequency of stools compared to no intervention (mean difference (MD) 2.24 times per week, 95% CI 0.96 to 3.52; 40 women, one study, moderate quality of evidence).
   
   Who: pregnant women with constipation; fiber supplementation versus no intervention, 1 study
   Effect: stool frequency MD +2.24 per week (95% CI 0.96 to 3.52); moderate quality
   Certainty: Indirect: the fiber in this study is not psyllium. Comparison stimulant vs bulk-forming is already in ev-psy-10, I do not repeat it.
   Cochrane Database Syst Rev, 2015 · checked 2026-10-07 · we read the abstract
3. ev-psypr-03 · Meta-analysis or systematic review · Cochrane systematic review of randomized and quasi-randomized trials · n = 180
   There is insufficient evidence to comprehensively assess the effectiveness and safety of interventions (pharmacological and non-pharmacological) for treating constipation in pregnancy, due to limited data (few studies with small sample size and no meta-analyses).
   
   Who: pregnant women with constipation; 4 studies included, 2 with 180 women contributing data
   Effect: no usable data on dehydration, electrolyte imbalance, acute allergic reaction or asthma; no meta-analysis possible
   Certainty: The main limit of knowledge for axis 6: safety was not measured, not established.
   Cochrane Database Syst Rev, 2015 · checked 2026-10-07 · we read the abstract
4. ev-psypr-04 · Position of an expert body · US regulation (21 CFR) · n = —
   Granular dosage forms containing psyllium (hemicellulose), psyllium hydrophilic mucilloid, psyllium seed, psyllium seed (blond), psyllium seed husks, plantago husks, or plantago seed
   
   Who: US over-the-counter laxative products in granular dosage form containing psyllium or plantago
   Effect: granular psyllium dosage forms not generally recognized as safe and effective; powders dissolved in liquid are not on this list
   Certainty: Regulatory decision on the dosage form (risk of esophageal obstruction), not about pregnancy. Full phrase: 'inadequate data to establish general recognition of the safety and effectiveness'. Does not change the rights for powder/capsules.
   21 CFR 310.545(a)(12)(i)(B), drug products containing certain active ingredients offered over-the-counter: bulk laxatives, approved as of March 29, 2007 · checked 2026-10-07 · we read the section
5. ev-psypr-05 · Position of an expert body · US regulation (21 CFR) · n = —
   Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking.
   
   Who: US over-the-counter products containing hydrophilic gums and mucilloids such as psyllium
   Effect: mandatory choking warning; at least 8 ounces (a full glass) of water or other fluid per dose
   Certainty: A general requirement, not specific to pregnancy; for pregnant women with nausea or vomiting it is especially relevant to remember fluid. The same quote as psyl-r1-13.
   21 CFR 201.319, water-soluble gums, hydrophilic gums, and hydrophilic mucilloids, required warnings · checked 2026-10-07 · we read the section
6. ev-psypr-06 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = 8 trials
   We found that additional dietary fiber supplements significantly reduced fasting glucose (Hedges’g = −0.3; 95% CI [−0.49, −0.1]), two-hour postprandial glucose (Hedges’g = −0.69; 95% CI [−0.88, −0.51]), glycated hemoglobin (Hedges’g = −0.5; 95% CI [−0.68, −0.31]), TC (Hedges’g = −0.44; 95% CI [−0.69, −0.19]), TG (Hedges’g = −0.3; 95% CI [−0.4, −0.2]) and LDL-C (Hedges’g = −0.48; 95% CI [−0.63, −0.33]).
   
   Who: pregnant women with gestational diabetes in 8 randomized controlled trials of added dietary fiber
   Effect: 2-h postprandial glucose g -0.69 (95% CI -0.88 to -0.51); fasting glucose g -0.30 (95% CI -0.49 to -0.1); HbA1c g -0.5; LDL-C g -0.48
   Certainty: Indirect: fiber types differ, psyllium not singled out. The authors themselves write about the need for higher-quality studies.
   Nutrients, 2022 · checked 2026-10-07 · we read the abstract
7. ev-psypr-07 · Randomized controlled trial(s) · randomized controlled trial · n = 376
   In addition, the intervention group showed lower need for constipation medication, and soluble fiber supplementation may offer potential benefits for GDM patients. Importantly, our study verified the safety of long-term soluble fiber supplementation during pregnancy.
   
   Who: 376 women between 11 and 13 weeks of gestation at high risk of metabolic syndrome
   Effect: lower need for constipation medication in the fiber group; safety asserted by the authors; adverse event counts not in the abstract
   Certainty: Indirect: the type of soluble fiber is not named in the abstract; no full text in PMC (no_pmc).
   Food Funct, 2024 · checked 2026-10-07 · we read the abstract
8. ev-psypr-08 · Observational data · prospective cohort study, questionnaire · n = 225
   frequently used products included peppermint tea for nausea (1.8%; n = 4), Psyllium Husk Fiber® for obstipation (6.7%; n = 15)
   
   Who: 225 pregnant Danish women at the gestational week 10 to 16 scan, Randers Regional Hospital
   Effect: psyllium husk use 6.7% (n = 15); the authors' table flags delayed absorption of other drugs as the pregnancy concern
   Certainty: Frequency of use, not consequences. Table 3 marks the risk as 'Delayed absorption of other drugs' (text truncated in the corpus).
   BMC Complement Altern Med, 2019 · checked 2026-10-07 · we read the fulltext
9. ev-psy-04 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials, adverse events narrative · n = —
   One study administering psyllium reported that 2 participants (18%) in the intervention group had abdominal pain, compared to none in the control group (28).
   
   Who: Psyllium trials within a meta-analysis of fiber in chronic constipation
   Effect: abdominal pain 18% vs 0% in one small trial; no serious adverse events in two psyllium trials
   Certainty: Adverse events were reported inconsistently and not pooled.
   Am J Clin Nutr, 2022 · checked 2026-10-06 · we read the fulltext
10. ev-psy-10 · Meta-analysis or systematic review · Cochrane systematic review of randomized and quasi-randomized trials · n = 140
    Compared to bulk-forming laxatives, pregnant women who received stimulant laxatives had significantly more improvement in constipation (risk ratio (RR) 1.59, 95% confidence interval (CI) 1.21 to 2.09; 140 women, one study, moderate quality of evidence), but also significantly more abdominal discomfort (RR 2.33, 95% CI 1.15 to 4.73; 140 women, one study, low quality of evidence)
    
    Who: Pregnant women with constipation, 4 studies included, 2 with 180 women contributing data
    Effect: improvement RR 1.59 (95% CI 1.21 to 2.09) for stimulant vs bulk-forming; abdominal discomfort RR 2.33 (1.15 to 4.73)
    Certainty: One trial of unclear randomization; moderate to low quality evidence. Bulk-forming laxatives were the comparator, not tested against placebo.
    Cochrane Database Syst Rev, 2015 · checked 2026-10-06 · we read the abstract
11. ev-psy-12 · Laboratory or animal data · case series · n = 1
    We report a case of a 60-year-old woman with no prior history of psyllium ingestion who developed anaphylactic symptoms after eating a psyllium-containing cereal. Her only previous exposure was dispensing a psyllium-containing laxative as a nurse.
    
    Who: One 60-year-old woman, previous exposure only by dispensing psyllium laxative
    Effect: IgE-mediated anaphylaxis confirmed by skin test and basophil histamine release
    Certainty: Single case. Shows sensitization by inhalation in people who handle the powder.
    JAMA, 1990 · checked 2026-10-06 · we read the abstract
12. ev-psy-13 · Laboratory or animal data · case series · n = 1
    Since patients undergoing extreme slimming regimens may cause intestinal obstruction if psyllium is taken without adequate fluid intake caution should be taken when eating psyllium.
    
    Who: One 26-year-old man on an extreme slimming regimen
    Effect: intestinal obstruction
    Certainty: Single case report.
    Acute Med Surg, 2023 · checked 2026-10-06 · we read the abstract